Prism
Commercial- Indications
- Post-traumatic stress disorder
Company intelligence / Profile preview
GrayMatters Health
Haifa, Haifa District, Israelgraymatters-health.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Prism for PTSD, the company’s flagship product, has FDA clearance as an adjunctive treatment for PTSD. In clinical trials, approximately 67% of patients showed clinically significant symptom improvement three months after completing treatment. The device has a low attrition rate (~10%) and mild side effects that self-resolve post-treatment. Prism does not require trauma re-exposure and can be operated by non-MDs in clinics.
- Therapeutic areas
- Psychiatry
- Modalities
- DeviceNon-pharmacological therapy (self-neuromodulation)Digital therapeutic
- Industry
- Digital Health Medical Devices
02
Drug pipeline
1 asset03
Partnerships
Collaborations with key medical institutions and academic centers including Tel Aviv University; further details not specified publicly.
Beyond the preview
Go deeper on GrayMatters Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GrayMatters Health.